Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

This study has been completed.
Sponsor:
Information provided by:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT01020656
First received: November 24, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.


Condition
Retinal Detachment

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Universitaire Dijon:

Enrollment: 206
Study Start Date: January 2009
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
group 1
patients with no anticoagulants used as the control group
group 2
patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)
group 3
patients treated with aspirin
group 4
patients treated with clopidogrel therapy
group 5
patients treated with both anticoagulant and aspirin medications
group 6
patients treated with both anticoagulant and clopidogrel medications
group 7
patients treated with both aspirin and clopidogrel medications

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery with peribulbar anesthesia.

Criteria

Inclusion Criteria:

  • Take or no anticoagulant treatment before surgery,
  • Vitreoretinal surgery

Exclusion Criteria:none

  • No surgery
  • Anesthetic complication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01020656

Locations
France
Ophthalmology Unit CHU Dijon
Dijon, Burgundy, France, 21000
Sponsors and Collaborators
Centre Hospitalier Universitaire Dijon
  More Information

No publications provided

Responsible Party: Professor Catherine Creuzot-Garcher, Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier: NCT01020656     History of Changes
Other Study ID Numbers: MARIE02
Study First Received: November 24, 2009
Last Updated: November 24, 2009
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by Centre Hospitalier Universitaire Dijon:
anticoagulant agents
antiplatelet agents
vitreoretinal surgery
Patients suffered from retinal detachment

Additional relevant MeSH terms:
Retinal Detachment
Retinal Diseases
Eye Diseases
Anticoagulants
Platelet Aggregation Inhibitors
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 15, 2014